Status:
COMPLETED
Minimally Invasive Flap With Platelet Rich Fibrin or Growth Factor Enhanced Matrix in Treatment of Intrabony Defect
Lead Sponsor:
Tanta University
Conditions:
Periodontal Regeneration
Eligibility:
All Genders
30-55 years
Phase:
PHASE2
Brief Summary
Twenty-one intra-bony defects in fifteen systemically healthy patients with moderate to severe chronic periodontitis were randomly classified into 3 groups, 7 sites each. Group І treated by MIST alone...
Detailed Description
: Twenty-one intra-bony defects in fifteen systemically healthy patients with moderate to severe chronic periodontitis were randomly classified into 3 groups, 7 sites each. Group І treated by MIST alo...
Eligibility Criteria
Inclusion
- • Presence of at least one tooth with PPD and CAL loss of ≥ 5 mm associated with an intra-bony defect of ≥ 2 mm according to Cortellini and Tonetti, 2007
Exclusion
- Patients with uncontrolled or poorly controlled diabetes, life-threatening conditions, or requiring antibiotic prophylaxis were excluded.
- Smokers
- Pregnant patients.
- Patients with aggressive periodontitis.
- Patients with multiple interconnected vertical defect walls.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04786327
Start Date
January 1 2018
End Date
October 1 2019
Last Update
June 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malak Mohamed Shoukheba
Tanta, Egypt, 020